ADCT Insider Trading Activity and SEC Form 4 Filings
ADCT insider trading summary
Over the past 12 months, insiders at ADC Therapeutics SA (ADCT) reported 18 sales worth $58.9M by 3 insiders and no open-market purchases on SEC Form 4. Net insider selling was $58.9M.
Latest ADCT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 2, 2026 | RedCo II Master Fund, L.P. | 10% Owner | Sell | $8.3M (2,529,491 @ $3.28) |
| Apr 2, 2026 | RedCo II Master Fund, L.P. | 10% Owner | Sell | $8.6M (2,634,506 @ $3.28) |
| Apr 2, 2026 | Jeremy Green | 10% Owner | Sell | $8.3M (2,529,491 @ $3.28) |
| Apr 2, 2026 | Jeremy Green | 10% Owner | Sell | $8.6M (2,634,506 @ $3.28) |
| Apr 2, 2026 | Redmile Group, LLC | 10% Owner | Sell | $8.6M (2,634,506 @ $3.28) |
| Apr 2, 2026 | Redmile Group, LLC | 10% Owner | Sell | $8.3M (2,529,491 @ $3.28) |
| Apr 1, 2026 | Jeremy Green | 10% Owner | Sell | $643K (169,265 @ $3.80) |
| Apr 1, 2026 | Redmile Group, LLC | 10% Owner | Sell | $643K (169,265 @ $3.80) |
| Apr 1, 2026 | RedCo II Master Fund, L.P. | 10% Owner | Sell | $643K (169,265 @ $3.80) |
| Apr 1, 2026 | Jeremy Green | 10% Owner | Sell | $617K (162,517 @ $3.80) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.